Chapter
Potential Solutions and Market Incentives for Drugs
06:54 - 13:17 (06:23)
The FDA's approval process for drugs can incentivize other startups to enter the market and potentially find a better solution. Additionally, a well-structured safety study can allow for faster market entry for drugs that are not harmful to humans.
Clips
Every Alzheimer's drug that has gone through the FDA has failed.
06:54 - 09:59 (03:05)
Alzheimer's
Summary
Every Alzheimer's drug that has gone through the FDA has failed. Those responsible for insurance payments bear the cost of treatment for those suffering from Alzheimer's.
ChapterPotential Solutions and Market Incentives for Drugs
EpisodeE35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The FDA's approach of fast-tracking drugs that demonstrate safety in studies can incentivize startups to enter the market of developing drugs for potential solutions.
09:59 - 13:17 (03:17)
FDA
Summary
The FDA's approach of fast-tracking drugs that demonstrate safety in studies can incentivize startups to enter the market of developing drugs for potential solutions. It could create a market that enables other players to find solutions in the long term.